Contact us
For General Inquiries Email: info@nirmidas.com
For Product Support Email: support@nirmidas.com
Published April 13, 2023. Stanford professor and Nirmidas co-founder, is interviewed by Nature Photonics to discuss the latest development on bioimaging in the second near-infrared (NIR-II) spectral window and its clinical potential.
The Biden administration announced Monday new details on how Americans can get free COVID-19 tests — or get reimbursements from their private insurance. This follows up on an announcement that the White House made last month.
To comply with regular shelf-life testing updates imposed by the FDA for MidaSpot® COVID-19 Antibody Combo Detection Kit to be maintained as an Emergency Use Authorization (EUA) product, the following lots have been extended until the new dates as shown below: Kit Lot NumberTest Card Lot NumberNew Expiration Date15933159322022.01.1716203162012022.01.3016401163992022.08.15 The FDA letter can be vi
Click Here for News on Businesswire Click Here for News on 360 DXLearn More about MidaSpot COVID-19 Antibody Combo Detection Kit How to Purchase MdiaSpot COVID-19 Antibody Combo Detection Kit
Nirmidas Biotech Inc. announces the availability of pGOLD™ COVID-19 IgG/IgM or IgG/IgM/IgA Assay kits for simultaneous, multiplexed detection of IgG, IgM and IgA antibodies against COVID-19, each assay requiring only 1 micro-liter of patient sera, plasma or whole blood (fresh or from dried spots on blood cards). This assay is initially for research use only. It will be eligible for LDT tests in clinical labs upon implementations.
“Rapid tests initially being launched to clinical diagnostics labs and healthcare workers for point-of-care-testing. These are suitable for doctor’s offices and ER rooms” - Silicon Valley Business Journal
https://www.bizjournals.com/sanjose/news/2020/03/19/stanford-startx-covid-19-coronavirus-startups.html